Kevin Charles Gorman serves as Executive at NEUROCRINE BIOSCIENCES INC, where they oversee executive responsibilities. Since joining the company, Kevin Charles Gorman has executed 111 insider transactions totaling $118.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 31, 2026 involved exercising options for 5,142 shares valued at $0.
Kevin Charles Gorman currently holds 516,893 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Charles Gorman has been a net seller of NBIX stock. They have purchased $1.0K and sold $118.8M worth of shares.
Kevin Charles Gorman's most recent insider trade was on Jan 31, 2026, when they sold 5,142 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $136.06 |
| Discretionary |
| Jan 31, 2026 | NBIX | $0 | Option Exercise | 5,142 | $N/A | Discretionary |
| Aug 7, 2025 | NBIX | $13.4M | Sale | 106,322 | $126.41 | Discretionary |
| Aug 7, 2025 | NBIX | $3.8M | Option Exercise | 106,322 | $35.99 | Discretionary |
| Jun 13, 2024 | XNCR | $0 | Award | 5,986 | $N/A | Discretionary |
| Feb 13, 2024 | NBIX | $100.0K | Option Exercise | 2,312 | $43.24 | Discretionary |
| Feb 13, 2024 | NBIX | $100.0K | Option Exercise | 2,778 | $35.99 | Discretionary |
| Feb 13, 2024 | XNCR | $1.0K | Purchase | 53 | $19.12 | Discretionary |
| Feb 13, 2024 | NBIX | $376.7K | Sale | 2,832 | $133.02 | Planned |
| Feb 8, 2024 | NBIX | $305.1K | Sale | 2,274 | $134.15 | Planned |
| Feb 6, 2024 | NBIX | $432.2K | Sale | 3,040 | $142.18 | Planned |
| Jan 31, 2024 | NBIX | $380.8K | Sale | 2,707 | $140.69 | Planned |
| Jan 9, 2024 | NBIX | $8.3M | Sale | 62,023 | $134.01 | Planned |
| Jan 9, 2024 | NBIX | $1.2M | Option Exercise | 62,023 | $19.59 | Planned |
| Jan 8, 2024 | NBIX | $14.0M | Sale | 105,835 | $132.44 | Planned |
| Jan 8, 2024 | NBIX | $2.1M | Option Exercise | 105,835 | $19.59 | Planned |
| Aug 21, 2023 | NBIX | $1.0M | Sale | 9,328 | $107.40 | Planned |
| Jun 20, 2023 | XNCR | $0 | Award | 5,007 | $N/A | Discretionary |
| Feb 8, 2023 | NBIX | $237.2K | Sale | 2,274 | $104.30 | Discretionary |
| Feb 7, 2023 | NBIX | $332.3K | Sale | 3,248 | $102.30 | Discretionary |
| Feb 7, 2023 | NBIX | $2.1M | Sale | 20,482 | $102.43 | Discretionary |
| Feb 6, 2023 | NBIX | $321.3K | Sale | 3,040 | $105.68 | Discretionary |
| Jan 31, 2023 | NBIX | $298.0K | Sale | 2,707 | $110.08 | Discretionary |
| Feb 8, 2022 | NBIX | $180.8K | Sale | 2,274 | $79.49 | Discretionary |
| Feb 7, 2022 | NBIX | $195.8K | Sale | 2,422 | $80.83 | Discretionary |
| Feb 7, 2022 | NBIX | $262.5K | Sale | 3,248 | $80.82 | Discretionary |
| Feb 7, 2022 | NBIX | $245.6K | Sale | 3,040 | $80.80 | Discretionary |
| Feb 8, 2021 | NBIX | $379.1K | Sale | 3,248 | $116.71 | Discretionary |
| Feb 8, 2021 | NBIX | $507.0K | Sale | 4,343 | $116.74 | Discretionary |